➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: August 5, 2020

DrugPatentWatch Database Preview

Permethrin - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for permethrin and what is the scope of freedom to operate?

Permethrin is the generic ingredient in three branded drugs marketed by Mylan, Actavis Labs, Encube Ethicals, Perrigo Israel, Glaxosmithkline, Medtech Products, Actavis Mid Atlantic, and Perrigo New York, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for permethrin. Eighteen suppliers are listed for this compound.

Drug Prices for permethrin

See drug prices for permethrin

Drug Sales Revenue Trends for permethrin

See drug sales revenues for permethrin

Recent Clinical Trials for permethrin

Identify potential brand extensions & 505(b)(2) entrants

Kenya Medical Research InstitutePhase 2
University of OxfordPhase 2
Manhiça Health Research Centre (CISM)Phase 2

See all permethrin clinical trials

Pharmacology for permethrin
Drug ClassPyrethroid
Medical Subject Heading (MeSH) Categories for permethrin

US Patents and Regulatory Information for permethrin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs PERMETHRIN permethrin CREAM;TOPICAL 074806-001 Jan 23, 1998 AB RX No No   Start Trial   Start Trial   Start Trial
Medtech Products NIX permethrin LOTION;TOPICAL 019918-001 May 2, 1990 OTC Yes Yes   Start Trial   Start Trial   Start Trial
Mylan ELIMITE permethrin CREAM;TOPICAL 019855-001 Aug 25, 1989 DISCN Yes No   Start Trial   Start Trial   Start Trial
Glaxosmithkline NIX permethrin LOTION;TOPICAL 019435-001 Mar 31, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.